Award
National Cancer Institute 10912598
Defining and targeting the lung cancer progenitor cell niche using a high-resolution, multi-omics approach
Recipient
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Award Amount
$54,538.00
Ceiling
$54,538.00
Awarded
August 15, 2025
Identifier
10912598
Award for research on lung cancer progenitor cell niche using multi-omics to identify therapeutic targets and biomarkers, led by Daniel Charytonowicz at Mount Sinai, funded by NCI.
Description
The project focuses on identifying transcriptomic profiles and surface markers specific to tumor initiating cells in non-small cell lung cancer, leveraging multi-scale sequencing and informatics tools. It involves multimodal sequencing approaches, including single-cell RNA sequencing and spatial transcriptomics, aiming to identify new therapeutic targets or prognostic biomarkers for NSCLC. The project is led by Daniel Charytonowicz at the ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI and funded by the National Cancer Institute (NCI).